(Q84897051)

English

Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention

scientific article published on 01 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

based on heuristic

inferred from title

atrial fibrillation

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Wolfgang Mueck

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Anthonie W A Lensing

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Giancarlo Agnelli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hervé Decousus

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Paolo Prandoni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Frank Misselwitz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

675-686

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21895039%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

https://scigraph.springernature.com/pub.10.2165/11595320-000000000-00000

0 references

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thromboembolism: disease burden, outcomes and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of venous thromboembolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor xa inhibitor--in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating population kinetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral rivaroxaban for symptomatic venous thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Summary of the article: Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011; 365: 1557-1559]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of renal aging in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of venous thromboembolism in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21895039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84897051&oldid=2143263454"